C. İRKEÇ Et Al. , "’Fractalkine (CX3CL1) in the sera of patients with multipl sclerosis and Neuro-Behcet’s disease’’," MSParis2017 , 2017
İRKEÇ, C. Et Al. 2017. ’Fractalkine (CX3CL1) in the sera of patients with multipl sclerosis and Neuro-Behcet’s disease’’. MSParis2017 .
İRKEÇ, C., Kuz, T., ALTIPARMAK, T., & FİDAN, I., (2017). ’Fractalkine (CX3CL1) in the sera of patients with multipl sclerosis and Neuro-Behcet’s disease’’ . MSParis2017
İRKEÇ, CEYLA Et Al. "’Fractalkine (CX3CL1) in the sera of patients with multipl sclerosis and Neuro-Behcet’s disease’’," MSParis2017, 2017
İRKEÇ, CEYLA Et Al. "’Fractalkine (CX3CL1) in the sera of patients with multipl sclerosis and Neuro-Behcet’s disease’’." MSParis2017 , 2017
İRKEÇ, C. Et Al. (2017) . "’Fractalkine (CX3CL1) in the sera of patients with multipl sclerosis and Neuro-Behcet’s disease’’." MSParis2017 .
@conferencepaper{conferencepaper, author={CEYLA İRKEÇ Et Al. }, title={’Fractalkine (CX3CL1) in the sera of patients with multipl sclerosis and Neuro-Behcet’s disease’’}, congress name={MSParis2017}, city={}, country={}, year={2017}}